These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 12817900

  • 1. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.
    Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A.
    Pharm Res; 2003 Jun; 20(6):931-6. PubMed ID: 12817900
    [Abstract] [Full Text] [Related]

  • 2. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G, Barthelmes J, Vetter A, Krieg C, Uhlschmied C, Bonn GK, Bernkop-Schnürch A.
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
    Bernkop-Schnürch A, Kast CE, Guggi D.
    J Control Release; 2003 Dec 05; 93(2):95-103. PubMed ID: 14636716
    [Abstract] [Full Text] [Related]

  • 6. Oral heparin delivery: design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system.
    Schmitz T, Leitner VM, Bernkop-Schnürch A.
    J Pharm Sci; 2005 May 05; 94(5):966-73. PubMed ID: 15793802
    [Abstract] [Full Text] [Related]

  • 7. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B, Xing Y, Zheng Y, Sun C, Liang G.
    Drug Deliv; 2016 May 05; 23(1):238-47. PubMed ID: 24865290
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development and evaluation of buccoadhesive tablet for selegiline hydrochloride based on thiolated polycarbophil.
    Wasnik MN, Godse RD, Nair HA.
    Drug Dev Ind Pharm; 2014 May 05; 40(5):632-8. PubMed ID: 24517570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and in vivo bioavailability study of an oral fondaparinux delivery system.
    Vetter A, Perera G, Leithner K, Klima G, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2010 Nov 20; 41(3-4):489-97. PubMed ID: 20705133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A.
    Biomaterials; 2006 Dec 20; 27(34):5855-60. PubMed ID: 16919723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.